Showing results (91-100 of 156) with videos related to
Sort By:
Pageof 16
Biochemical and Biophysical Research Communications|July 29, 1983
In vitro binding and in vivo clearance of human alpha 2-macroglobulin after reaction with endoproteases from four different classesS R Feldman, K A Ney, S L Gonias, et al.Biochimica Et Biophysica Acta|January 21, 1997
Characterization of alpha 2-macroglobulin receptor low density lipoprotein receptor-related protein (alpha 2 MR/LRP) in White Carneau pigeon peritoneal macrophages: its role in lipoprotein metabolismT Seo, H C Wang, S R Feldman, et al.Skin Pharmacology and Applied Skin Physiology|June 5, 2003
Bioavailability of clobetasol propionate in different vehiclesT J Franz, P A Lehman, S R Feldman, et al.The British Journal of Dermatology|January 19, 2020
A changed life: the life experiences of patients with psoriasis receiving biological treatmentB Trettin, S R Feldman, F Andersen, et al.Archives of Biochemistry and Biophysics|September 1, 1984
Conformation-specific precipitation of human alpha 2-macroglobulin by divalent zinc or calf thymus histone H3S L Gonias, S R Feldman, C W Pratt, et al.Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 1, 1998
Characteristics of office-based visits for skin cancer. Dermatologists have more experience than other physicians in managing malignant and premalignant skin conditionsE S Smith, S R Feldman, A B Fleischer, et al.Journal of the American Academy of Dermatology|November 21, 1997
Procedures for skin diseases performed by physicians in 1993 and 1994: analysis of data from the National Ambulatory Medical Care SurveyA B Fleischer, S R Feldman, R E White, et al.The British Journal of Dermatology|January 6, 2009
Economic evaluation of systemic therapies for moderate to severe psoriasisS Sizto, N Bansback, S R Feldman, et al.The British Journal of Dermatology|May 15, 2009
Using 'number needed to treat' to help conceptualize the magnitude of benefit and risk of tumour necrosis factor-alpha inhibitors for patients with severe psoriasisJ W Dharamsi, M Bhosle, R Balkrishnan, et al.Archives of Dermatology|February 15, 2001
The primary care provider and the care of skin disease: the patient's perspectiveD G Federman, M Reid, S R Feldman, et al.Pageof 16